SCHEMBL21730404

SCHEMBL21730404

CN1CC2CC[C@@H](C1)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14876645 1.00
SCHEMBL50733 1.00
SCHEMBL17188945 1.00
Hydrochloric Acid SCHEMBL271156 0.97 CHRNB2 (0.39)
Hydrochloric Acid SCHEMBL29920122 0.97 CHRNB2 (0.39)
Hydrochloric Acid SCHEMBL611862 0.97 CHRNB2 (0.39)
SCHEMBL705004 0.88 CHRNB2 (0.35)
SCHEMBL24240867 0.84
SCHEMBL3936594 0.84
SCHEMBL16242450 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230190-A1 PYRIMIDINE BASED MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. (US) 2023-11-30 WO disclosed
WO-2023150284-A2 QUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-08-10 WO disclosed
WO-2020035052-A1 PYRAZINE COMPOUNDS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2020-02-20 WO disclosed